Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures

Journal of Clinical Pharmacology

Volumn 38, Issue 2, 1998, Pages 166-171

  Kochak, Gregory M ^a   Page, John G ^b,c   Buchanan, Robert A ^d   Peters, Richard ^a   Padgett, Claire S ^b,c  

^a Kansas City Analytical Services   (United States)

^b IBRD Rostrum Global   (United States)

^c IBRD Rostrum Global   (United States)

^d Dainippon Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZONISAMIDE;

ADULT; ANXIETY NEUROSIS; AREA UNDER THE CURVE; ARTICLE; COMPLEX PARTIAL SEIZURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFICACY; HEADACHE; HUMAN; HUMAN EXPERIMENT; MENTAL DEFICIENCY; MENTAL IRRITATION; NAUSEA; SIDE EFFECT; STEADY STATE;

EID: 0031883882     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04406.x     Document Type: Article

References (8)

1. Seino M, Naruto S, Ito T, Miyazaki H: Zonisamide. In, Levy RH, Mattson RH, Meldrum BS (eds.): Antiepileptic Drugs. Fourth edition. New York: Raven Press, 1995;1011-1024.
2. Taylor CP, McLean JR, Bockbrader HN, Buchanan RA, Karasawa T, Miyazaki H, et al: Zonisamide (AD-810, CI912). In, Meldrum BS, Porter RJ (eds.): New Anticonvulsant Drugs. John Libbey, London, 1986;277-294.
3. Noguchi H, Tomita N, Yoshida K, Maeda T, Arakawa S, Dodo H, Naruto S: Simultaneous HPLC determination of zonisamide and other antiepileptic drugs in human serum. Jpn Pharmacol Ther 1988;16:4805-4811.
4. Kochak GM, Smith RA, Choi RL, John V, Tipnis V, Honc F, et al: Intra-and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617. Pharm Res 1989;6:328-331.
5. Kochak GM: Population characteristics of biological systems influenced by multicomponent random and uniform variation. Pharm Res 1992;9:345-349.
6. Leppik I, Willmore L, Homan R, Fromm G, Oommen K, Penry J, et al: Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 1993;14:165-173.
7. Schmidt D, Jacob R, Loiseau P, Deisenhammer E, Klinger D, Despland A, et al: Zonisamide for add-on treatment of refractory partial epilepsy: a European double blind trial. Epilepsy Res 1993;15:67-73.
8. Stiff DD, Robicheau JT, Zemaitis MA: Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative. Xenobiotica 1992;22:1-11.